The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 44,604,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | |||
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 5,104,925 | 1,126,915 | SH | SOLE | 1,126,915 | 0 | 0 | |||
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 36,239,842 | 500,827 | SH | SOLE | 500,827 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 17,692,339 | 118,383 | SH | SOLE | 118,383 | 0 | 0 | |||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 29,450,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | |||
APPLE INC | COM | 037833100 | 31,373,981 | 182,960 | SH | SOLE | 182,960 | 0 | 0 | |||
ARRIVENT BIOPHARMA INC | COM | 04272N102 | 19,237,720 | 1,077,140 | SH | SOLE | 1,077,140 | 0 | 0 | |||
ASML HOLDING N V | N Y REGISTRY SHS | N07059210 | 177,145,712 | 182,536 | SH | SOLE | 182,536 | 0 | 0 | |||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 39,303,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 34,019,262 | 358,626 | SH | SOLE | 358,626 | 0 | 0 | |||
BROOKFIELD ASSET MANAGMT LTD | CL A LMT VTG SHS | 113004105 | 26,355,238 | 627,207 | SH | SOLE | 627,207 | 0 | 0 | |||
BROOKFIELD CORP | CL A LTD VT SH | 11271J107 | 162,465,230 | 3,880,230 | SH | SOLE | 3,880,230 | 0 | 0 | |||
CABLE ONE INC | COM | 12685J105 | 50,099,861 | 118,403 | SH | SOLE | 118,403 | 0 | 0 | |||
CARGO THERAPEUTICS INC | COM | 14179K101 | 27,900,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | |||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 60,742,209 | 2,411,362 | SH | SOLE | 2,411,362 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 51,425,466 | 1,098,600 | SH | SOLE | 1,098,600 | 0 | 0 | |||
EDGEWISE THERAPEUTICS INC | COM | 28035Q102 | 115,722,403 | 6,344,430 | SH | SOLE | 6,344,430 | 0 | 0 | |||
GALECTO INC | COM | 36322Q107 | 1,948,277 | 2,497,791 | SH | SOLE | 2,497,791 | 0 | 0 | |||
INSMED INC | COM PAR $.01 | 457669307 | 36,335,318 | 1,339,304 | SH | SOLE | 1,339,304 | 0 | 0 | |||
INSPIRE MED SYS INC | COM | 457730109 | 14,073,900 | 65,524 | SH | SOLE | 65,524 | 0 | 0 | |||
IO BIOTECH INC | COM | 449778109 | 8,802,686 | 5,088,258 | SH | SOLE | 5,088,258 | 0 | 0 | |||
KYVERNA THERAPEUTICS INC | COM | 501976104 | 17,388,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | |||
LANZATECH GLOBAL INC | COM | 51655R101 | 48,946,945 | 15,814,845 | SH | SOLE | 15,814,845 | 0 | 0 | |||
LEXEO THERAPEUTICS INC | COM | 52886X107 | 25,688,513 | 1,638,298 | SH | SOLE | 1,638,298 | 0 | 0 | |||
MARQETA INC | CLASS A COM | 57142B104 | 2,631,686 | 441,558 | SH | SOLE | 441,558 | 0 | 0 | |||
METAGENOMI INC | COM | 59102M104 | 18,348,296 | 1,739,175 | SH | SOLE | 1,739,175 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 37,680,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
PHARVARIS N V | COM | N69605108 | 26,993,173 | 1,168,030 | SH | SOLE | 1,168,030 | 0 | 0 | |||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 28,287,000 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | |||
SALESFORCE INC | COM | 79466L302 | 144,614,589 | 480,160 | SH | SOLE | 480,160 | 0 | 0 | |||
SPERO THERAPEUTICS INC | COM | 84833T103 | 806,511 | 468,902 | SH | SOLE | 468,902 | 0 | 0 | |||
TREACE MED CONCEPTS INC | COM | 89455T109 | 4,698,000 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 57,721,950 | 845,000 | SH | SOLE | 845,000 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 19,261,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | |||
VERVE THERAPEUTICS INC | COM | 92539P101 | 26,560,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 |